Comparative pharmacokinetics of chlorphenesin carbamate and methocarbamol in man
β Scribed by Arlington A. Forist; Ray W. Judy
- Publisher
- John Wiley and Sons
- Year
- 1971
- Tongue
- English
- Weight
- 364 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
Serum drug levels following oral administration of large single doses of chlorphenesin carbamate and methocarbamol were fitted to a one-compartment open model. The appearance of each drug was described by a short lag time followed by a rapid first-order absorption and attainment of maximum levels. No statistically significant differences were found between estimates of mean lag times (to, 0.5 and 0.2 hr.), half-lives for absorption (tiln, 0.4 and 0.6 hr ), and times for attainment of maximum serum concentrations (t,,,, 1.9 and 1.4 hr.) for chlorphenesin carbamate and methocarbamol, respectively. Chlorphenesin carbamate was distributed throughout a significantly larger relative volume (1.27 uersus 0.48 l./kg.) and yielded a correspondingly smaller maximum serum concentration (15.3 uersus 29.8 mcg./ml., 2-g. dose). The mean biological half-life for chlorphenesin carbamate, 3.14 hr., was significantly greater than the value of 1.20 hr. obtained for methocarbamol.
Key phrases 0 Chlorphenesin carbamate-pharmacokinetic parameters, compared to methocarbamol, man [7 Methocarbamolpharmacokinetic parameters, compared to chlorphenesin carbamate, man c] Pharmacokinetic parameters-comparative, chlorphenesin carbamate and methocarbamol, man 0 Plasma levelscomparative, chlorphenesin carbamate and methocarbamol, man
π SIMILAR VOLUMES
In a pharmacokinetic study, 15, 30, 60, and 150 mg kg-' intravenous and oral doses of methocarbamol were administered to rats. Differences observed in plasma clearance values, i.e. 0~0203,0~0156,0~0123, and 0-0085 1 kg-' min-' for 15,30,60, and 150 mg kg-', respectively, suggested a dosedependent ph
The pharmacokinetics of two pyridinol carbamate formulations were studied after a single oral administration in 10 healthy volunteers. An open one-compartment model described the evolution of plasma concentrations as a function of time. Pyridinol carbamate was rapidly absorbed (mean lag time from 0.
## Abstract The pharmacokinetics of chlorbutol were studied after oral administration in 4 healthy subjects on two occasions. Following the rapid attainment of peak concentrations, plasma concentrations fell by approximately 50 per cent in 24 h. After the first dose of chlorbutol, the terminal elim